Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen's Neuroscience Strategy Includes De-Risking The Pipeline

magnetic resonance image (MRI) of the brain human

Related Content

Biogen Builds Out Neuroscience Niche With Ischemic Stroke Drug

May 15 2017

Biogen Staying "Laser-Focused" On Neuroscience

Apr 25 2017

Biogen Builds In Neurodegenerative Disease With Anti-Tau Deal

Apr 13 2017

Neuroscience Reaches A New Inflection Point, Big Biotechs Say

Jan 25 2017

2Q Pharma Results Preview: Lilly, Biogen, Amgen, GSK And Gilead

Jul 21 2017

Related Companies

Biogen, Inc.

Ionis Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Remedy Pharmaceuticals Inc.

Roche Holding AG

Additional Topics

Sales & Earnings Business Strategies Commercial Companies Neurology BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window